Neurobehaviorally inactive cannabinoid that acts as a selective agonist for GPR55 (EC50
values are 2.5, >30 and >30 μ
M at GPR55, CB1
receptors respectively). Increases phosphorylation of protein kinases in, and migration of, human umbilical vein endothelial cells.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg et al.
Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery.
Ho and Hiley
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
Jarai et al.
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1.
Mo et al.
The citations listed below are publications that use Tocris products. Selected citations for Abn-CBD include:
Showing Results 1 - 3 of 3